SLXN
Silexion Therapeutics Corp
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Under these circumstances, in accordance with the requirements of Accounting Standards Codification (“ASC”) 205-40, management has concluded that there is substantial doubt about the Company’s ability to continue as a going concern, as management believes its current funds will be sufficient to fund its operations for only several months from the date these financial statements are issued.”View the 10-Q filed May 15, 2026
Company with tickers: SLXN, SLXNW
Market Cap
$9.29M
Shares Outstanding
3,330,785
CIK
2022416
CUSIP
G1281K130
13F Activity (30d)
2 filings
1 filers
Website
Visit website
Investor Relations
Investor relations
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-05-28 | 108,443 | $0.42 | $45,546 |
| 2026-05-27 | 138,388 | $0.43 | $59,507 |
| 2026-05-26 | 643,636 | $0.50 | $321,818 |
| 2026-05-22 | 2,018,936 | $0.48 | $969,089 |
| 2026-05-21 | 3,422,183 | $0.53 | $1,813,757 |
| 2026-05-20 | 9,078 | $0.27 | $2,451 |
| 2026-04-15 | 39 | $1.04 | $41 |
| 2026-03-27 | 22,818 | $1.31 | $29,892 |
Showing 1–8 of 8 settlements